Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription 23.02.2026 1 Arch Virol 1 BMC Pediatr 1 BMJ 2 Clin Infect Dis 1 J Infect 2 J Infect Dis 5 J Virol 1 Pediatr Infect Dis J 1 PLoS Comput Biol 6 PLoS One 2 Science 16 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. AHMAD MM, Gulzar MW, Azeem MW, Mubashar MM, et al
   Molecular Detection and Phylogenetic Characterization of Avian Infectious Bronchitis Virus (IBV) in Vaccinated Commercial Chicken Flocks Experiencing Outbreaks in Faisalabad, Pakistan.
   Arch Virol. 2026;171:73.
   PubMed        
   
   

   
   BMC Pediatr

2. AKELLO F, Achen S, Najjuma F, Musiime V, et al
   Tetanus infection in an 11-year-old male with full infant vaccination history: a rare case report.
   BMC Pediatr. 2026 Feb 16. doi: 10.1186/s12887-026-06588.
   PubMed        
   
   

   
   BMJ

3. BARANIUK C
   FDA reverses stance on Moderna vaccine.
   BMJ. 2026;392:s339.
   PubMed        
   
   

   
   Clin Infect Dis

4. MAYER EF, Falsey AR, Wolfe CR, Herc E, et al
   RSV Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.
   Clin Infect Dis. 2026 Feb 18:ciag108. doi: 10.1093.
   PubMed         Abstract available
   
   
5. SUMSUZZMAN DM, Shi C, Moghadas SM
   Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalisation and Emergency Department Visits Associated with Respiratory Syncytial Virus in Older Adults: A Meta-Analysis.
   Clin Infect Dis. 2026 Feb 18:ciag107. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

6. D'ABRAMO A, Colavita F, Ponzetta L, De Marco P, et al
   The DENGVAC Study: Preliminary Findings on the Immunogenicity of the TAK-003 Dengue Vaccine.
   J Infect. 2026 Feb 18:106707. doi: 10.1016/j.jinf.2026.106707.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. SMITH D, Weir IR, Ramirez S, Coelho CH, et al
   Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
   J Infect Dis. 2026 Feb 17:jiag091. doi: 10.1093.
   PubMed         Abstract available
   
   
8. BAR-OR I, Weil M, Assraf H, Kabat A, et al
   Clinical and Environmental Surveillance of Poliovirus Type 2 Outbreak Using a Novel Specific Real-time Quantitative Polymerase Chain Reaction Assay, Israel, 2022-2023.
   J Infect Dis. 2026;233:342-350.
   PubMed         Abstract available
   
   

   
   J Virol

9. ZHAO Y, Ma Q, Jiao C, Liu J, et al
   Recombinant duck enteritis virus harboring the hemagglutinin genes of influenza virus rapidly induces specific cellular immunity in ducks.
   J Virol. 2025 Dec 30:e0201425. doi: 10.1128/jvi.02014.
   PubMed         Abstract available
   
   
10. HAZELL NC, Reyna RA, Adam A, Bonam SR, et al
    mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal models.
    J Virol. 2026 Jan 7:e0189725. doi: 10.1128/jvi.01897.
    PubMed         Abstract available
    
    
11. CONG G, Li H, Li L, Chen J, et al
    The newly developed porcine-origin parainfluenza virus PIV5-JS17 serves as an exogenous gene delivery system for swine.
    J Virol. 2026 Jan 13:e0185825. doi: 10.1128/jvi.01858.
    PubMed         Abstract available
    
    
12. PARRA GI, Ford-Siltz LA, Pilewski KA, Tohma K, et al
    Variable and conserved B cell epitopes of GII.4 human noroviruses.
    J Virol. 2026;100:e0180425.
    PubMed         Abstract available
    
    
13. BRIGLEB PH, Sharp B, Lazure L, Livingston B, et al
    Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses.
    J Virol. 2026 Jan 22:e0208825. doi: 10.1128/jvi.02088.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

14. QIU L, Pan H, Liang Q, Chen Z, et al
    Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
    Pediatr Infect Dis J. 2026 Feb 18. doi: 10.1097/INF.0000000000005184.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

15. UTAZI CE, Chaudhuri S, Wariri O, Olowe ID, et al
    An age-structured spatially varying coefficient model for high-resolution mapping of vaccination coverage.
    PLoS Comput Biol. 2026;22:e1013989.
    PubMed         Abstract available
    
    

    
    PLoS One

16. SULIS G, Maredia N, Wolfson C, Basta NE, et al
    Correction: Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018-2021 follow-up 2 survey.
    PLoS One. 2026;21:e0343252.
    PubMed         Abstract available
    
    
17. NOREEN K, Khalid SN, Noor M, Maryam S, et al
    Cultural adaptation and content validation of the WHO BeSD framework for HPV vaccination in Pakistan: A two-phase Delphi and cognitive interview study.
    PLoS One. 2026;21:e0335358.
    PubMed         Abstract available
    
    
18. THAKKAR N, Oteri AJ, McCarthy KA
    Routine immunization intensification, vaccination campaigns, and measles transmission in Southern Nigeria.
    PLoS One. 2026;21:e0341016.
    PubMed         Abstract available
    
    
19. ZHANG X, Thomas MH, Lynch A, Shi H, et al
    Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets.
    PLoS One. 2026;21:e0339613.
    PubMed         Abstract available
    
    
20. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
    Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
    PLoS One. 2026;21:e0341888.
    PubMed         Abstract available
    
    
21. THAKUR A, Meza-Torres B, Fan X, Byford R, et al
    Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study.
    PLoS One. 2026;21:e0336449.
    PubMed         Abstract available
    
    

    
    Science

22. LESLIE M
    Unorthodox 'vaccine' offers broad protection in mice.
    Science. 2026;391:753.
    PubMed         Abstract available
    
    
23. ZHANG H, Floyd K, Fang Z, Hoffmann FA, et al
    Mucosal vaccination in mice provides protection from diverse respiratory threats.
    Science. 2026 Feb 19:eaea1260. doi: 10.1126/science.aea1260.
    PubMed         Abstract available
    
    

    
    Vaccine

24. CHANDRA LA, Nugroho DB, Thobari JA, Dimaguila GL, et al
    Active surveillance methods to identify adverse events of special interest (AESIs) following vaccination against pandemic diseases: A scoping review.
    Vaccine. 2026;77:128341.
    PubMed         Abstract available
    
    
25. LOEHR J, Moser CA, Asturias EJ, Shaw AC, et al
    Science for vaccine policy: Lack of transparency, misinformation, and poor decision processes at the December 2025 ACIP meeting.
    Vaccine. 2026;76:128338.
    PubMed         Abstract available
    
    
26. PERCIO J, Silva RMA, Lopez AM, Cabral CM, et al
    What is the impact of the safety signal on dengue vaccination coverage among adolescents in Brazil?
    Vaccine. 2026;77:128355.
    PubMed         Abstract available
    
    
27. AL-ABBOODI A, Falih IQ, Al-Asadi M, Hussein BA, et al
    Iron-oxide nanoparticles (SPIONs) enhance malaria vaccine antibody response.
    Vaccine. 2026;77:128353.
    PubMed         Abstract available
    
    
28. KASONGA JN, Hoff NA, Merritt S, Fandema E, et al
    Comparing sampling approaches for assessing sub-national vaccination coverage: a pilot study in Central African Republic and the Democratic Republic of Congo.
    Vaccine. 2026;76:128313.
    PubMed         Abstract available
    
    
29. MISHRA PM, Chaudhary S, Manhas RS, Lokwani SR, et al
    A novel hypothetical protein (SAUSA300_1684) confers excellent protection against multi-drug-resistant Staphylococcus aureus infection in the murine model.
    Vaccine. 2026;75:128220.
    PubMed         Abstract available
    
    
30. MWALE M
    Persistent measles immunization gaps in LMICs: Insights from the 2024 revision of the WHO/UNICEF estimates of National Immunization Coverage.
    Vaccine. 2026;75:128298.
    PubMed         Abstract available
    
    
31. REVIE NM, Guo MY, Mullin AE, Excler JL, et al
    The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges ahead.
    Vaccine. 2026;76:128339.
    PubMed         Abstract available
    
    
32. TRUONG HC, Pham QD, Phan TV, Vo DTT, et al
    Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease in Vietnamese children prior to national introduction: A matched case-control study.
    Vaccine. 2026;77:128349.
    PubMed         Abstract available
    
    
33. MAK TS, Chan KS, Yu OY, Lee VH, et al
    HPV vaccine discussion and administration in dental primary healthcare settings for oropharyngeal cancer prevention: A systematic review from dental patients' perspectives.
    Vaccine. 2026;76:128335.
    PubMed         Abstract available
    
    
34. GREEN MA, Jeffery C, Cheyne C, Bonnett L, et al
    Learning from the outliers: A longitudinal ecological study of social and spatial inequalities in older adult influenza vaccination and hospitalisation (Cheshire and Merseyside, UK, 2018-19 to 2023-24).
    Vaccine. 2026;77:128356.
    PubMed         Abstract available
    
    
35. CONTARINO F, Fiorilla C, Bella F, Leonforte F, et al
    Missed opportunities and co-administration patterns for influenza vaccination in older adults in Italy: a retrospective cohort study.
    Vaccine. 2026;77:128366.
    PubMed         Abstract available
    
    
36. SOBLE A, Koh M, Taaffe J, Procter SR, et al
    Evaluating the broader impact of improved influenza vaccines: A full value of vaccine assessment approach.
    Vaccine. 2026;60 Suppl 2:128166.
    PubMed         Abstract available
    
    
37. MADLEY-DOWD P, Horne EMF, Hulme WJ, Palmer TM, et al
    Effectiveness of bivalent BA.1 mRNA booster vaccines during the autumn 2022 COVID-19 booster programme in adults aged 50+ in England: observational matched cohort study using OpenSAFELY.
    Vaccine. 2026 Feb 18:128276. doi: 10.1016/j.vaccine.2026.128276.
    PubMed         Abstract available
    
    
38. AMOAKO N, Cohuet S, Adjei MR, Gurry C, et al
    COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024.
    Vaccine. 2026 Feb 17:128310. doi: 10.1016/j.vaccine.2026.128310.
    PubMed         Abstract available
    
    
39. MADNI SA, Olson CK, Zauche LH, Machefsky A, et al
    Risk of spontaneous abortion after mRNA COVID-19 vaccination received just prior to or during pregnancy: Complete data from CDC COVID-19 vaccine pregnancy registry.
    Vaccine. 2026;76:128340.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum